Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.

Publikation

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.

Wissenschaftlicher Artikel/Review - 30.04.2019

Seiffge David Julian, Paciaroni Maurizio, Wilson Duncan, Koga Masatoshi, Macha Kosmas, Cappellari Manuel, Schaedelin Sabine A, Shakeshaft Clare, Takagi Masahito, Tsivgoulis Georgios, Bonetti Bruno, Kallmünzer Bernd, Arihiro Shoji, Alberti Andrea, Polymeris Alexandros A, Ambler Gareth, Yoshimura Sohei, Venti Michele, Bonati Leo H, Muir Keith, Yamagami Hiroshi, Thilemann Sebastian, Altavilla Riccardo, Peters Nils, Inoue Manabu, Bobinger Tobias, Agnelli Giancarlo, Brown Martin M, Sato Shoichiro, Acciarresi Monica, Jäger Hans Rolf, Bovi Paolo, Schwab Stefan, Lyrer Philippe A, Caso Valeria, Toyoda Kazunori, Werring David J, Engelter Stefan T, De Marchis Gian Marco, CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators

Zitation

Seiffge D, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, Schaedelin S, Shakeshaft C, Takagi M, Tsivgoulis G, Bonetti B, Kallmünzer B, Arihiro S, Alberti A, Polymeris A, Ambler G, Yoshimura S, Venti M, Bonati L, Muir K, Yamagami H, Thilemann S, Altavilla R, Peters N, Inoue M, Bobinger T, Agnelli G, Brown M, Sato S, Acciarresi M, Jäger H, Bovi P, Schwab S, Lyrer P, Caso V, Toyoda K, Werring D, Engelter S, De Marchis G, CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 2019; 85:823-834.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Ann Neurol 2019; 85

Veröffentlichungsdatum

30.04.2019

eISSN (Online)

1531-8249

Seiten

823-834

Kurzbeschreibung/Zielsetzung

We compared outcomes after treatment with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) and a recent cerebral ischemia.